Literature DB >> 17329344

Lytic and latent antigens of the human gammaherpesviruses Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus induce T-cell responses with similar functional properties and memory phenotypes.

Florian Bihl1, Murli Narayan, John V Chisholm, Leah M Henry, Todd J Suscovich, Elizabeth E Brown, Tania M Welzel, Daniel E Kaufmann, Tauheed M Zaman, Sheila Dollard, Jeff N Martin, Fred Wang, David T Scadden, Kenneth M Kaye, Christian Brander.   

Abstract

The cellular immunity against Kaposi's sarcoma-associated herpesvirus (KSHV) is poorly characterized and has not been compared to T-cell responses against other human herpesviruses. Here, novel and dominant targets of KSHV-specific cellular immunity are identified and compared to T cells specific for lytic and latent antigens in a second human gammaherpesvirus, Epstein-Barr virus. The data identify a novel HLA-B57- and HLA-B58-restricted epitope in the Orf57 protein and show consistently close parallels in immune phenotypes and functional response patterns between cells targeting lytic or latent KSHV- and EBV-encoded antigens, suggesting common mechanisms in the induction of these responses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17329344      PMCID: PMC1900166          DOI: 10.1128/JVI.02509-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  HLA and AIDS: a cautionary tale.

Authors:  S J O'Brien; X Gao; M Carrington
Journal:  Trends Mol Med       Date:  2001-09       Impact factor: 11.951

2.  The functional profile of primary human antiviral CD8+ T cell effector activity is dictated by cognate peptide concentration.

Authors:  Michael R Betts; David A Price; Jason M Brenchley; Karin Loré; F Javier Guenaga; Anna Smed-Sorensen; David R Ambrozak; Stephen A Migueles; Mark Connors; Mario Roederer; Daniel C Douek; Richard A Koup
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

3.  Identification of CD8+ T cell epitopes within lytic antigens of human herpes virus 8.

Authors:  Eliana Ribechini; Cinzia Fortini; Mauro Marastoni; Serena Traniello; Susanna Spisani; Paolo Monini; Riccardo Gavioli
Journal:  J Immunol       Date:  2006-01-15       Impact factor: 5.422

4.  Impact of HLA-B alleles, epitope binding affinity, functional avidity, and viral coinfection on the immunodominance of virus-specific CTL responses.

Authors:  Florian Bihl; Nicole Frahm; Loriana Di Giammarino; John Sidney; Mina John; Karina Yusim; Tonia Woodberry; Kaori Sango; Hannah S Hewitt; Leah Henry; Caitlyn H Linde; John V Chisholm; Tauheed M Zaman; Eunice Pae; Simon Mallal; Bruce D Walker; Alessandro Sette; Bette T Korber; David Heckerman; Christian Brander
Journal:  J Immunol       Date:  2006-04-01       Impact factor: 5.422

5.  Consistent cytotoxic-T-lymphocyte targeting of immunodominant regions in human immunodeficiency virus across multiple ethnicities.

Authors:  Nicole Frahm; B T Korber; C M Adams; J J Szinger; R Draenert; M M Addo; M E Feeney; K Yusim; K Sango; N V Brown; D SenGupta; A Piechocka-Trocha; T Simonis; F M Marincola; A G Wurcel; D R Stone; C J Russell; P Adolf; D Cohen; T Roach; A StJohn; A Khatri; K Davis; J Mullins; P J R Goulder; B D Walker; C Brander
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

6.  HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells.

Authors:  Michael R Betts; Martha C Nason; Sadie M West; Stephen C De Rosa; Stephen A Migueles; Jonathan Abraham; Michael M Lederman; Jose M Benito; Paul A Goepfert; Mark Connors; Mario Roederer; Richard A Koup
Journal:  Blood       Date:  2006-02-07       Impact factor: 22.113

7.  The evolutionarily conserved Kaposi's sarcoma-associated herpesvirus ORF57 protein interacts with REF protein and acts as an RNA export factor.

Authors:  Poonam Malik; David J Blackbourn; J Barklie Clements
Journal:  J Biol Chem       Date:  2004-05-20       Impact factor: 5.157

8.  Kaposi's sarcoma-associated herpesvirus cytotoxic T lymphocytes recognize and target Darwinian positively selected autologous K1 epitopes.

Authors:  Justin Stebbing; Dimitra Bourboulia; Margaret Johnson; Stephen Henderson; Ian Williams; Natalie Wilder; Mervyn Tyrer; Mike Youle; Nesrina Imami; Toru Kobu; Wolfgang Kuon; Joachim Sieper; Frances Gotch; Chris Boshoff
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

9.  CD8+ immunodominance among Epstein-Barr virus lytic cycle antigens directly reflects the efficiency of antigen presentation in lytically infected cells.

Authors:  Victoria A Pudney; Alison M Leese; Alan B Rickinson; Andrew D Hislop
Journal:  J Exp Med       Date:  2005-01-31       Impact factor: 14.307

10.  Simultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices, anti- CD3 mAb T-cell expansion and "RecycleSpot"

Authors:  Florian K Bihl; Elisabetta Loggi; John V Chisholm; Hannah S Hewitt; Leah M Henry; Caitlyn Linde; Todd J Suscovich; Johnson T Wong; Nicole Frahm; Pietro Andreone; Christian Brander
Journal:  J Transl Med       Date:  2005-05-11       Impact factor: 5.531

View more
  16 in total

1.  Generation of HIV-1-specific CD8+ cell responses following allogeneic hematopoietic cell transplantation.

Authors:  Ann E Woolfrey; Uma Malhotra; Robert D Harrington; John McNevin; Thomas J Manley; Stanley R Riddell; Robert W Coombs; Frederick R Appelbaum; Larry Corey; Rainer Storb
Journal:  Blood       Date:  2008-08-12       Impact factor: 22.113

2.  Regulatory T Cell Effect on CD8+ T Cell Responses to Human Herpesvirus 8 Infection and Development of Kaposi's Sarcoma.

Authors:  Lauren M Lepone; Giovanna Rappocciolo; Paolo A Piazza; Diana M Campbell; Frank J Jenkins; Charles R Rinaldo
Journal:  AIDS Res Hum Retroviruses       Date:  2017-03-02       Impact factor: 2.205

3.  Monofunctional and polyfunctional CD8+ T cell responses to human herpesvirus 8 lytic and latency proteins.

Authors:  Lauren Lepone; Giovanna Rappocciolo; Emilee Knowlton; Mariel Jais; Paolo Piazza; Frank J Jenkins; Charles R Rinaldo
Journal:  Clin Vaccine Immunol       Date:  2010-08-18

Review 4.  Adaptive immune responses to Kaposi's sarcoma-associated herpesvirus.

Authors:  Angela Nalwoga; Denise Whitby
Journal:  Curr Opin Immunol       Date:  2022-07-08       Impact factor: 7.268

5.  Treatment-dependent loss of polyfunctional CD8+ T-cell responses in HIV-infected kidney transplant recipients is associated with herpesvirus reactivation.

Authors:  O Gasser; F Bihl; S Sanghavi; C Rinaldo; D Rowe; C Hess; D Stablein; M Roland; P Stock; C Brander
Journal:  Am J Transplant       Date:  2009-04       Impact factor: 8.086

6.  Kaposi's sarcoma-associated herpesvirus-encoded viral IRF3 modulates major histocompatibility complex class II (MHC-II) antigen presentation through MHC-II transactivator-dependent and -independent mechanisms: implications for oncogenesis.

Authors:  Jianmin Zuo; Andrew D Hislop; Carol S Leung; Shereen Sabbah; Martin Rowe
Journal:  J Virol       Date:  2013-02-28       Impact factor: 5.103

7.  Design, expression, and processing of epitomized hepatitis C virus-encoded CTL epitopes.

Authors:  Daniel Yerly; David Heckerman; Todd Allen; Todd J Suscovich; Nebojsa Jojic; Carl Kadie; Werner J Pichler; Andreas Cerny; Christian Brander
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

8.  Viral adaptation to immune selection pressure by HLA class I-restricted CTL responses targeting epitopes in HIV frameshift sequences.

Authors:  Christoph T Berger; Jonathan M Carlson; Chanson J Brumme; Kari L Hartman; Zabrina L Brumme; Leah M Henry; Pamela C Rosato; Alicja Piechocka-Trocha; Mark A Brockman; P Richard Harrigan; David Heckerman; Daniel E Kaufmann; Christian Brander
Journal:  J Exp Med       Date:  2010-01-11       Impact factor: 14.307

9.  Professional antigen presenting cells in human herpesvirus 8 infection.

Authors:  Emilee R Knowlton; Lauren M Lepone; Jun Li; Giovanna Rappocciolo; Frank J Jenkins; Charles R Rinaldo
Journal:  Front Immunol       Date:  2013-01-21       Impact factor: 7.561

10.  The T-Cell Immune Response against Kaposi's Sarcoma-Associated Herpesvirus.

Authors:  Rebecca C Robey; Salvinia Mletzko; Frances M Gotch
Journal:  Adv Virol       Date:  2011-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.